Abstract

BackgroundPharmacological and psychological intervention combined are proved to be more effective for treating psychosis than pharmacological treatment alone. Cognitive Behavioral Therapy for psychosis (CBTp) has been empirically supported as conjoint treatment providing a significant improvement in positive and negatives symptoms, and functional outcomes for psychosis. However, rates of patient discontinuation in CBTp and occasional lack of improvement in symptoms show it is important to refine the identification of the individual characteristics related to better response to CBTp. This literature review aims to accomplish a comprehensive analysis of the evidence-based studies that have searched predictors in the last decades, focusing on individual factors that directly predicts responsiveness to CBTp, rather than therapist or treatment factors. The scope of knowledge gathered here intends to guide practical application of CBTp to people with psychosis that can benefit more from this intervention. Adaptations to improve the effectiveness of CBTp and gaps to be addressed in further research are also considered.MethodsThirty (30) studies (18 RCT) were included to determine which characteristics are relevant for a distinctive response to CBTp in people with schizophrenia and other psychotic disorders. The word “predictor” was used to discriminate pertinent studies. Articles were included if they reported in a population within a Psychosis Spectrum Disorder; reported on CBT or derived intervention; reported on individual predictors of outcome in CBT or derived therapy. Articles that reported on a high-risk psychosis population or on comorbidities with psychosis; reported non-individual predictors; were case studies or literature reviews; had a small sample; and had mixed interventions and did not report results specific to CBT were not included.ResultsStudies have shown divergences in methodology, focus on different domains and time-points of disorders outcome and great heterogeneity in results. There is strong evidence that greater clinical and cognitive insight, cognitive flexibility, greater positive symptom severity and less pronounced negative symptoms at baseline, shorter duration of psychosis, a greater number of hospitalization in the previous five years and pre-therapy coping styles can predict better outcome in CBTp, although their significance has varied between studies. While impairment in verbal memory was related to a shortage of improvement in symptoms and a greater likelihood to abandon of treatment before completion, most studies did not find neurocognitive functioning to be a predictor of outcome in CBTp.DiscussionFurther investigation is needed to determine the extent and validity of these predictors in different populations within the scope of psychosis. Professionals can benefit from the gathered knowledge, using these findings to better target CBTp and to focus early stages of intervention on developing patient’s abilities such as cognitive flexibility and insight, working memory, coping skills and clinical awareness in order to improve their receptiveness to therapy and successful outcome.Future research should aim to replicate findings with larger and more diagnosis-comprehensive samples to enable generalization of the present results. Aspects such as personality traits, metacognition and sociodemographic characteristics require more thorough investigation to confirm their predictive value before being taken into consideration when selecting patient suitability to CBTp and similar interventions.

Highlights

  • Cognitive deficits are common in people with schizophrenia and have a negative impact on functioning

  • The results indicate that Cognitive Remediation (CR) may benefit people with schizophrenia in different way depending on their age

  • Age may represent a large number of complex factors and more work is needed in this area to better understand how individual characteristics and illness history may influence CR response

Read more

Summary

Background

Relapse of schizophrenia is common, has profound, adverse consequences for patients and is costly to health services. Signs interventions aim to use warning signs of deterioration to prevent full relapse. This study aimed to evaluate the feasibility and acceptability of using the ExPRESS smartphone app to monitor both conventional early signs and basic symptoms as possible predictors of relapse. Methods: Patients who had experienced a relapse of schizophrenia within the past year took part in a screening interview. Those with at least one basic symptom emerging prior to a previous relapse were eligible for the longitudinal feasibility study. Consenting participants were asked to use the ExPRESS smartphone app once a week for 6 months, answering questions on their experience of conventional early signs, basic symptoms and psychotic symptoms. Initial findings from sixteen qualitative interviews are discussed, including interviews with the two participants who met relapse criteria and two study drop-outs

Results

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.